Bromide

Bromide

SCHEMBL3664435

Br.O=C1C(Br)CN(Cc2ccccc2)CC1c1ccccc1Cl.O=C1CCN(Cc2ccccc2)CC1c1ccccc1Cl

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 3/20 0.41
TACR1 P25103 6/20 0.46
GRIN1 Q05586 1/20 0.41
GRIN2B Q13224 1/20 0.41
DPP4 P27487 1/20 0.38
S1PR5 Q9H228 2/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1616827 0.91 DPP4 (0.43) SIGMAR1DPP4S1PR5S1PR1
SCHEMBL1617423 0.89 TACR1 (0.56) TACR1SIGMAR1GRIN1GRIN2BDPP4
Bromide SCHEMBL3663120 0.80 TACR1 (0.42) TACR1SIGMAR1
Bromide SCHEMBL2381446 0.78 TACR1 (0.61) TACR1SIGMAR1GRIN1GRIN2B
SCHEMBL731081 0.77 TACR1 (0.62) TACR1SIGMAR1GRIN1GRIN2B
SCHEMBL3554063 0.75 TACR1 (0.54) TACR1SIGMAR1GRIN1GRIN2B
SCHEMBL1400959 0.73 TACR1 (0.61) TACR1SIGMAR1GRIN1GRIN2B
SCHEMBL29246345 0.72 TACR1 (0.57) TACR1SIGMAR1GRIN1GRIN2B
SCHEMBL6440459 0.71 TACR1 (0.64) TACR1SIGMAR1
Bromide SCHEMBL1617121 0.71 SLC6A2 (0.41) SIGMAR1GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231629-A1 MODULATORS FOR AMYLOID BETA F. Hoffmann-La Roche AG (CH) 2010-09-29 EP disclosed
WO-2009087127-A1 MODULATORS FOR AMYLOID BETA F. HOFFMANN-LA ROCHE AG (CH) 2009-07-16 WO disclosed